CN103055215A - Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk - Google Patents

Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk Download PDF

Info

Publication number
CN103055215A
CN103055215A CN2013100017737A CN201310001773A CN103055215A CN 103055215 A CN103055215 A CN 103055215A CN 2013100017737 A CN2013100017737 A CN 2013100017737A CN 201310001773 A CN201310001773 A CN 201310001773A CN 103055215 A CN103055215 A CN 103055215A
Authority
CN
China
Prior art keywords
radix
nasopharyngeal carcinoma
tianschanicum
seselopsis
schischk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100017737A
Other languages
Chinese (zh)
Other versions
CN103055215B (en
Inventor
马长林
杨干波
姜俊芝
Original Assignee
马长林
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 马长林 filed Critical 马长林
Priority to CN201310001773.7A priority Critical patent/CN103055215B/en
Publication of CN103055215A publication Critical patent/CN103055215A/en
Application granted granted Critical
Publication of CN103055215B publication Critical patent/CN103055215B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk. The Chinese herba preparation comprises the raw material components at a weight ratio: immature bitter orange 28-32, elecampane 4-15, semen litchi 8-12, codonopsis pilosula 4-15, radix peucedani 13-17, pine stump 13-17, caulis spatholobi 13-17, coptis chinensis 8-12, ginseng 4-15, hull of water chestnut 4-15, lucid ganoderma 8-12, ligusticum wallichii 8-12, seselopsis tianschanicum schischk 28-32, rhizoma sparganii 1-5, pangolin 13-17, trogopterus dung 28-32, radix tinosporae 13-17, sticktight 1-5, turpinia formosana nakai 8-12, lycoris rosea 28-32, iphigenia indica 4-15, and native copper 28-32. Based on the Fu Zheng Pei Ben principle, the Chinese herba preparation uses the characteristics of seselopsis tianschanicum schischk, and cooperates with traditional Chinese medicine taking the effects of reinforcing qi and nourishing blood, activating blood and dissolving stasis, clearing away heat and toxic materials, relieving swelling and pain and the like, so that the advantage that the treatment effect on patents with nasopharyngeal carcinoma is good and quick is achieved.

Description

A kind of Chinese medicine preparation that utilizes the radical cure of XIGUI celery to treat nasopharyngeal carcinoma
Technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine preparation that utilizes the radical cure of XIGUI celery to treat nasopharyngeal carcinoma.
Background technology:
Nasopharyngeal carcinoma refers to betide the malignant tumor of cavum nasopharyngeum top and sidewall.Be one of China's malignant tumor occurred frequently, sickness rate is first of the ear,nose ﹠ throat malignant tumor.Common symptoms is for being with blood, ear suffocation sense, auditory dysesthesia, diplopia and headache etc. in nasal obstruction, the tears.
At present, the field of Chinese medicines for the treatment of nasopharyngeal carcinoma has the following disadvantages: one, effect is obvious not; Two, take effect slow, can not timely and effective inhibition throat tumor growth, transfer, diffusion.
Summary of the invention:
The object of the invention is exactly in order to remedy the defective of prior art, and a kind of Chinese medicine preparation that utilizes the radical cure of XIGUI celery to treat nasopharyngeal carcinoma is provided, it have advantages of curative effect obviously, instant effect.
The present invention is achieved by the following technical solutions:
A kind of Chinese medicine preparation that utilizes the radical cure of XIGUI celery to treat nasopharyngeal carcinoma, it is characterized in that: the weight proportion of its each raw material components is: Fructus Aurantii Immaturus 28-32, Radix Aucklandiae 4-15, Semen Litchi 8-12, Radix Codonopsis 4-15, Radix Peucedani 13-17, Radix Pini massonianae 13-17, Caulis Spatholobi 13-17, Rhizoma Coptidis 8-12, Radix Ginseng 4-15, Shell of Water Chestnut 4-15, Ganoderma 8-12, Rhizoma Chuanxiong 8-12, XIGUI celery root 28-32, rhizoma sparganic 1-5, Squama Manis 13-17, Oletum Trogopterori 28-32, Radix Tinosporae 13-17, Herba Bidentis Bipinnatae 1-5, Turpinia arguta Seem 8-12, Flos Rosae Rugosae Bulbus Lycoridis Radiatae 28-32, Pseudobulbus Cremastrae Seu Pleiones 4-15, Pyritum 28-32.
A kind of Chinese medicine preparation that utilizes the radical cure of XIGUI celery to treat nasopharyngeal carcinoma, it is characterized in that: the weight proportion of its each raw material components is: Fructus Aurantii Immaturus 30, the Radix Aucklandiae 6, Semen Litchi 10, Radix Codonopsis 6, Radix Peucedani 15, Radix Pini massonianae 15, Caulis Spatholobi 15, Rhizoma Coptidis 10, Radix Ginseng 6, Shell of Water Chestnut 6, Ganoderma 10, Rhizoma Chuanxiong 10, XIGUI celery root 30, rhizoma sparganic 3, Squama Manis 15, Oletum Trogopterori 30, Radix Tinosporae 15, Herba Bidentis Bipinnatae 3, Turpinia arguta Seem 10, Flos Rosae Rugosae Bulbus Lycoridis Radiatae 30, Pseudobulbus Cremastrae Seu Pleiones 6, Pyritum 30.
XIGUI celery root, function cures mainly: stasis-dispelling and pain-killing; Nourishing blood for regulating menstruation.Main traumatic injury; Menoxenia; Dysmenorrhea; Blood deficiency and yellow complexion.
Advantage of the present invention is:
Chinese medicine of the present invention utilizes the characteristic of XIGUI celery root and cooperates the Chinese medicine formulas such as benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, reducing swelling and alleviating pain in line with the principle of the body resistance strengthening and constitution consolidating, has good effect for Nasopharyngeal Carcinoma Patients, the advantage of instant effect.
The specific embodiment:
A kind of Chinese medicine preparation that utilizes the radical cure of XIGUI celery to treat nasopharyngeal carcinoma, the weight of its each raw material components (g) is: Fructus Aurantii Immaturus 30, the Radix Aucklandiae 6, Semen Litchi 10, Radix Codonopsis 6, Radix Peucedani 15, Radix Pini massonianae 15, Caulis Spatholobi 15, Rhizoma Coptidis 10, Radix Ginseng 6, Shell of Water Chestnut 6, Ganoderma 10, Rhizoma Chuanxiong 10, XIGUI celery root 30, rhizoma sparganic 3, Squama Manis 15, Oletum Trogopterori 30, Radix Tinosporae 15, Herba Bidentis Bipinnatae 3, Turpinia arguta Seem 10, Flos Rosae Rugosae Bulbus Lycoridis Radiatae 30, Pseudobulbus Cremastrae Seu Pleiones 6, Pyritum 30.
Take by weighing above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
The present invention has good curative effect for proof, enumerates model case as follows:
Case one:
Blue certain, the man 60 years old, in October, 2010, because of epistaxis, cough to examination in hospital, is diagnosed as nasopharyngeal carcinoma.Give chemotherapeutic treatment, DeGrain, and also body is day by day become thin.Give treatment by Chinese herbs of the present invention, take one month after, cough is clearly better; Continued to take 3 months, weight in patients increases, and the state of an illness is clearly better.Existing stable disease.
Case two:
In certain, man, 58 years old.The main suit: epistaxis, cough, spirit are poor, malaise is also with symptoms such as tinnitus.Be diagnosed as nasopharyngeal carcinoma to examination in hospital.After give Chinese medicine of the present invention, behind the first quarter moon, the headache transference cure; Take continuously one and a half months, the nasopharynx part lump obviously dwindles; Continue to take half a year, patient's nasopharynx part lump dwindles, existing stable disease.
Case three:
Gong, woman, 53 years old.Main suit: epistaxis, headache, weak, weight loss.Be diagnosed as nasopharyngeal carcinoma to examination in hospital.It is carried out chemotherapeutic treatment, and the side effect such as nausea and vomiting appear in the patient after the chemotherapy.After take Chinese medicine of the present invention.Behind the first quarter moon, patient's spirit is clearly better; Continued to take one month, lump reduces to some extent; Take so far, conditions of patients is stable always.

Claims (2)

1. one kind is utilized the XIGUI celery to effect a radical cure the Chinese medicine preparation for the treatment of nasopharyngeal carcinoma, and it is characterized in that: the weight proportion of its each raw material components is: Fructus Aurantii Immaturus 28-32, Radix Aucklandiae 4-15, Semen Litchi 8-12, Radix Codonopsis 4-15, Radix Peucedani 13-17, Radix Pini massonianae 13-17, Caulis Spatholobi 13-17, Rhizoma Coptidis 8-12, Radix Ginseng 4-15, Shell of Water Chestnut 4-15, Ganoderma 8-12, Rhizoma Chuanxiong 8-12, XIGUI celery root 28-32, rhizoma sparganic 1-5, Squama Manis 13-17, Oletum Trogopterori 28-32, Radix Tinosporae 13-17, Herba Bidentis Bipinnatae 1-5, Turpinia arguta Seem 8-12, Flos Rosae Rugosae Bulbus Lycoridis Radiatae 28-32, Pseudobulbus Cremastrae Seu Pleiones 4-15, Pyritum 28-32.
2. a kind of Chinese medicine preparation that utilizes XIGUI celery radical cure to treat nasopharyngeal carcinoma according to claim 1, it is characterized in that: the weight proportion of its each raw material components is: Fructus Aurantii Immaturus 30, the Radix Aucklandiae 6, Semen Litchi 10, Radix Codonopsis 6, Radix Peucedani 15, Radix Pini massonianae 15, Caulis Spatholobi 15, Rhizoma Coptidis 10, Radix Ginseng 6, Shell of Water Chestnut 6, Ganoderma 10, Rhizoma Chuanxiong 10, XIGUI celery root 30, rhizoma sparganic 3, Squama Manis 15, Oletum Trogopterori 30, Radix Tinosporae 15, Herba Bidentis Bipinnatae 3, Turpinia arguta Seem 10, Flos Rosae Rugosae Bulbus Lycoridis Radiatae 30, Pseudobulbus Cremastrae Seu Pleiones 6, Pyritum 30.
CN201310001773.7A 2013-01-05 2013-01-05 Traditional Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk Expired - Fee Related CN103055215B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310001773.7A CN103055215B (en) 2013-01-05 2013-01-05 Traditional Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310001773.7A CN103055215B (en) 2013-01-05 2013-01-05 Traditional Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk

Publications (2)

Publication Number Publication Date
CN103055215A true CN103055215A (en) 2013-04-24
CN103055215B CN103055215B (en) 2014-05-07

Family

ID=48098309

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310001773.7A Expired - Fee Related CN103055215B (en) 2013-01-05 2013-01-05 Traditional Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk

Country Status (1)

Country Link
CN (1) CN103055215B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1155428A (en) * 1996-10-26 1997-07-30 迟经惠 Medicine for relieving nasal passage and throat
CN1383880A (en) * 2002-05-20 2002-12-11 张俊峰 Tumor treating pill
CN101327309A (en) * 2007-06-21 2008-12-24 尧抚人 Chinese medicine for treating lymph cancer, nasopharyngeal carcinoma and brain cancer
CN101352561A (en) * 2008-05-04 2009-01-28 北京中科仁和科技有限公司 Chinese medicinal composition for treating nasopharyngeal carcinoma and preparation method thereof
CN100457158C (en) * 2005-04-18 2009-02-04 潘文祥 Medicine for fortifying human body immune function
CN101564464B (en) * 2009-06-01 2011-04-06 朱志真 Chinese medicament for adjusting organism immunity of tumor patients

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1155428A (en) * 1996-10-26 1997-07-30 迟经惠 Medicine for relieving nasal passage and throat
CN1383880A (en) * 2002-05-20 2002-12-11 张俊峰 Tumor treating pill
CN100457158C (en) * 2005-04-18 2009-02-04 潘文祥 Medicine for fortifying human body immune function
CN101327309A (en) * 2007-06-21 2008-12-24 尧抚人 Chinese medicine for treating lymph cancer, nasopharyngeal carcinoma and brain cancer
CN101352561A (en) * 2008-05-04 2009-01-28 北京中科仁和科技有限公司 Chinese medicinal composition for treating nasopharyngeal carcinoma and preparation method thereof
CN101564464B (en) * 2009-06-01 2011-04-06 朱志真 Chinese medicament for adjusting organism immunity of tumor patients

Also Published As

Publication number Publication date
CN103055215B (en) 2014-05-07

Similar Documents

Publication Publication Date Title
CN100356972C (en) Chinese medicine for treating amblyopia and myopia
CN102600426B (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN103041203A (en) Traditional Chinese medicine formula for treating chronic pyelonephritis
CN102526306A (en) Chinese medicinal composition for treating ulcerative colitis
CN104147359A (en) Traditional Chinese medicine granule for relieving cough and resolving phlegm and preparation method thereof
CN103071112B (en) Traditional Chinese medicine for curing nasopharynx cancer
CN103055215B (en) Traditional Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk
CN103071099B (en) Traditional Chinese medicine for treatment of lung cancer by pink reineckea herb
CN104083554A (en) Traditional Chinese medicinal composition for treating pruritus vulvae
CN104248712A (en) Cough relieving and phlegm resolving traditional Chinese medicine particle electuary and preparation method thereof
CN104547543A (en) Traditional Chinese medicine composition for treating anemia
CN102988712A (en) Traditional Chinese medicine for treating cough and preparation method of traditional Chinese medicine
CN103055214B (en) Traditional Chinese medicine for treating nasopharynx cancer by utilizing lepidogrammitis intermedia
CN102846962A (en) Pharynx soothing tea
CN101985006A (en) Traditional Chinese herbal medicine for treating vaginal discharge diseases
CN103656123A (en) Traditional Chinese medicine composition for treating epididymitis
CN103751565A (en) Traditional Chinese medicinal composition for treating hypertension
CN103041041B (en) Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer
CN102847067B (en) Pharynx clearing pill
CN103099950A (en) Traditional Chinese medicine preparation for treating anemogenous toothache
CN101732568B (en) Chinese medicinal oral liquid for treating cancer and preparation method thereof
CN101099818A (en) Traditional Chinese medicine formula for treating leucoderma
CN105194222A (en) Traditional Chinese medicine preparation for treating cold and preparation method thereof
CN103933361A (en) Chinese herbal preparation for treating nasopharynx cancer by utilizing athyrium sinense
CN105560808A (en) Traditional Chinese medicine formula for relieving coughing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140507

Termination date: 20160105

EXPY Termination of patent right or utility model